2024-07-11 12:23:44
If you think that the The covid-19 pandemic It’s over, that’s right, but what’s not over is finding treatments for the disease. Do you remember that in January 2022 – in the middle of the pandemic – it was approved Pfizer anti-Covid drug: Paxlovid? It was a domain of emergency usewhile testing continues to demonstrate its effectiveness and safety.
Then you have learned that research has Pfizer by Paxlovid in patients at low risk of getting sick from Covid-19 does not affect the progression of the disease. That’s why there was talk of a improper use of the drug.
Later we learned more things, such as those researchers from the inside Birth of General Birgham (a network of non-profit doctors and hospitals in Boston, United States) shows that one in five patients taking Paxlovid to treat symptoms of Covid-19 later in a positive test after initial recovery. Furthermore, some of these people experienced the eliminate live and contagious viruses. We had a phenomenon known as virological rebound.
Well, despite all these problems, the manufacturer has followed how to continue to take advantage of the treatment, and now what is published is that Paxlovid «It has no apparent effect against persistent Covid symptoms«. Wow, since there is no longer a pandemic, but many people are left with consequences like that Covid stability (your reasons are not in doubt…) because we look for business in this new reference.
Hipra’s Bimervax Covid vaccine
The above is something similar to the Bimervax vaccinefrom the Spanish laboratory Hyper, against the coronavirus. They’re a little late to the “team,” aren’t they? They started in 2020 – in the middle of the pandemic, and now clinical trials will begin… in children. Well the HH-3 test, started in May 2023 and taken by the University Hospital of Vall d’Hebronfocused on young people aged 12 to less than 18 years.
Its something to know safety of Bimervax booster dose and know for sure if this dose is taken vaccine response against Covid-19. Currently, more than 200 young people participate in the study, and with the inclusion of two Primary Care Centers (CAP) in Peralada and Centelles, it is expected to reach the goal of 300 volunteers.
They said from the laboratory that “due to the promising initial results of the HH-3 test”, the European Medicines Agency (EMA) authority to study HH-6 in children from 5 to less than 12 years. The first phase of HH-6 will focus on identifying the optimal dose of the vaccine through its evaluation effect and safety. The second phase will analyze the ability of the vaccine to induce a vaccine response in one year, comparing these data with those obtained in young people.
That is to say, it has been known for a long time that Covid practically does not affect children or young people, and if they catch it it almost passes without knowing. eat doctors who warn about the nonsense of vaccinating children for this. But no, no. And there is damage from Covid vaccines in children.
Him 14th Pharmacovigilance Report on Immunization Covid 19 of the Spanish Pharmaceutical Company (Aemps) document in this way. In fact, it shows 74 serious adverse reactions in children. That is, reactions that require hospitalization, urgent medical attention, disabilities or any other important medical sign.
What has been said, then there is nothing, to continue vaccine testing on healthy children they don’t need and you can hurt them.
#Covid #pandemic #drugs #continue #tested #population